Academic Journal
Q1Journal of the American Pharmacists Association
About Journal of the American Pharmacists Association
About Journal of the American Pharmacists Association
Journal of the American Pharmacists Association is a peer-reviewed scholarly journal published by Elsevier B.V. (United States). It focuses on Q1. Publication coverage spans 2003-2026.
Key indicators: ISSN 1544-3191, 1544-3450; H-index 78.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (78): Strong citation impact — 78 articles cited at least 78 times each, reflecting solid influence.
Publishing in Journal of the American Pharmacists Association
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
- Submission: Submit via the official journal website.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Journal of the American Pharmacists Association?
1544-3191, 1544-3450.
Who publishes Journal of the American Pharmacists Association?
Elsevier B.V..
What are Journal of the American Pharmacists Association's metrics?
H-index 78.
Where do I submit to Journal of the American Pharmacists Association?
Via the official website.
Is Journal of the American Pharmacists Association peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Pharmaceutical Practices and Patient Outcomes; Medication Adherence and Compliance; Opioid Use Disorder Treatment; Diverse Scientific and Economic Studies; Pharmaceutical studies and practices; Vaccine Coverage and Hesitancy.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
3,230.00 USD; 3,020.00 EUR; 2,590.00 GBP; 400,620.00 JPY
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Effectiveness of a digital health-enabled community pharmacy counseling intervention for type 2 diabetes management: A pre-post study in South Korea
Chang Ok Choi, Xiaoxiao Chen, Chun Bae Park, Hyun Cheol Chung et al.
2027-01 · DOI: 10.1016/j.japh.2026.103525Challenges and outcomes of pharmacist billing and revenue in a hospital-based primary care setting
Haley Huddleston, Joseph Ben Hill, Nathan Lamberton, Sarah J. Billups et al.
2027-01 · DOI: 10.1016/j.japh.2026.103527Performance of large language models on narrow therapeutic index drug monitoring: Implications for clinical pharmacy practice
Helia Azmakan, Tahmour Azmakan
2027-01 · DOI: 10.1016/j.japh.2026.103524Artificial intelligence and machine learning in pharmaceutical research and health care: Ethical challenges and a framework for responsible implementation
Rima Hajjo, Osama H. Abusara, Dima A. Sabbah, Rahaf Zidan et al.
2026-11 · DOI: 10.1016/j.japh.2026.103490Community pharmacists' perceptions of long-acting injectable buprenorphine administration in community pharmacies: A cross-sectional survey study
Grace Marley, Brianna Farrell, Delesha Carpenter
2026-11 · DOI: 10.1016/j.japh.2026.103489Lessons for the remaining U.S. states seeking pharmacist authority to prescribe self-administered hormonal contraceptives
Grace C. Soilis, Kelsey L. Hake, Deirdre A. Quinn, Dana Loll et al.
2026-11 · DOI: 10.1016/j.japh.2026.103515Applications of behavioral economics–based nudge theory in hospital pharmacy practice: A scoping review
Quanyuan Huang, Hongyu Yang, Xiao Lu, Mingyu Huang et al.
2026-11 · DOI: 10.1016/j.japh.2026.103492Hypomagnesemia from malabsorption and renal magnesium wasting treated with high-dose magnesium glycinate: A case report
Bao Anh C. Tran, Tori Miller
2026-11 · DOI: 10.1016/j.japh.2026.103496Pharmacy-based distribution of nutrition and food resources in a safety-net health system
Alexis I. Zamora, Jaclyn Lewis Albin, Anisha Ganguly, Jillian Smartt et al.
2026-11 · DOI: 10.1016/j.japh.2026.103514Pharmacist decision-making in clinical calculations using binary sex variables for transgender patients
Jessica Sinclair, Kaitlyn Pierson, Kayla R. Joyner
2026-11 · DOI: 10.1016/j.japh.2026.103491The impact of socio-demographic determinants on rational drug use literacy among aging populations: A meta-analysis and systematic review
Pongpan Suriyong, Thawari Khansamrong, Siriwadee Bunyamahote, Titinun Auamnoy et al.
2026-11 · DOI: 10.1016/j.japh.2026.103495A financial equilibrium analysis of the publicly traded U.S. pharmacy sector, 2010–2024
Grant H. Skrepnek, Matthew C. Dickson, Eric J. Johnson
2026-11 · DOI: 10.1016/j.japh.2026.103521Cardiovascular risk factor measurement patterns in patients with severe mental illness receiving comprehensive medication management pharmacist care
R. May O'Donnell, Alicia Zagel, Katharine Heins, Rachel Carpentier et al.
2026-11 · DOI: 10.1016/j.japh.2026.103520Pharmacist-led antimicrobial stewardship: A systematic review of implementation barriers, facilitators, and policy-to-practice gaps in Bangladesh
Shumonto Mowla Chowdhury, Hyacinth Ukuhor, Rasha Abdelsalam Elshenawy
2026-11 · DOI: 10.1016/j.japh.2026.103511Pharmacist test-and-treat authority and empirical antibiotic prescribing: Evidence from state Medicaid data
Taylor Le, Thomas Kelly
2026-11 · DOI: 10.1016/j.japh.2026.103512Electronic collection of medication adherence patient-reported outcomes data in community pharmacies: Pilot implementation outcomes
Margie E. Snyder, Katelyn N. Hettinger-Riddell, Bonyan Qudah, Lisa A. Hillman et al.
2026-11 · DOI: 10.1016/j.japh.2026.103504Expanding access to medications for opioid use disorder through pharmacist scope-of-practice flexibility
Alex J. Adams
2026-11 · DOI: 10.1016/j.japh.2026.103522The path I didn’t plan
Tessa Lynne Rife-Pennington
2026-11 · DOI: 10.1016/j.japh.2026.103493Use of pharmaceutical pictograms in medication-use contexts: A systematic review
Francisco Javier Ferreira-Alfaya, Pilar Bas-Sarmiento, Martina Fernández-Gutiérrez
2026-11 · DOI: 10.1016/j.japh.2026.103505Marijuana scheduling snapshot: A rapid 50-state and D.C. survey
Zachary D. Smith, Rachel E. Barenie
2026-11 · DOI: 10.1016/j.japh.2026.103498Reviews
Community Reviews
Version History
October 9, 2026 at 10:18 pm
October 2, 2026